Concord Wealth Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-31
Closed -$303 – 1022
2024
Q2
$303 Hold
31
– – ﹤0.01% 783
2024
Q1
$468 Hold
31
– – ﹤0.01% 814
2023
Q4
$668 Sell
31
-80
-72% -$1.48K ﹤0.01% 773
2023
Q3
$2.06K Sell
111
-144
-56% -$3.36K ﹤0.01% 865
2023
Q2
$6.46K Buy
255
+111
+77% +$2.79K ﹤0.01% 666
2023
Q1
$3.73K Sell
144
-1,792
-93% -$48K ﹤0.01% 720
2022
Q4
$45.8K Buy
+1,936
New +$52.2K 0.01% 392
2022
Q3
– Sell
-4,350
Closed -$144K – 1035
2022
Q2
$144K Buy
4,350
+3,118
+253% +$132K 0.04% 208
2022
Q1
$89K Sell
1,232
-224
-15% -$16.1K 0.02% 316
2021
Q4
$134K Buy
1,456
+1,006
+224% +$120K 0.03% 259
2021
Q3
$57K Sell
450
-449
-50% -$65.4K 0.02% 195
2021
Q2
$149K Buy
899
+129
+17% +$20.9K 0.04% 173
2021
Q1
$140K Buy
770
+756
+5,400% +$175K 0.05% 168
2020
Q4
$3K Buy
+14
New +$2.85K ﹤0.01% 499

Other funds holding TDOC

Concord Wealth Partners's TDOC Position: Q3 2024 in Review

Concord Wealth Partners sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 31 shares — an estimated $303 sold.

Concord Wealth Partners first reported a position in TDOC in Q4 2020 and held it in 14 quarters. The position peaked at $149K in Q2 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Concord Wealth Partners reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Concord Wealth Partners sold 31 Teladoc Health shares in Q3 2024, an estimated $303.
  • Concord Wealth Partners first reported a position in Teladoc Health in Q4 2020 and held it in 14 quarters.
  • Concord Wealth Partners's Teladoc Health position peaked at $149K in Q2 2021.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Concord Wealth Partners's 13F filing for Q3 2024, filed 24 Oct 2024.